| European Case Law Identifier: | ECLI:EP:BA:2014:T210610.20140204 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 04 February 2014 | ||||||||
| Case number: | T 2106/10 | ||||||||
| Application number: | 02776926.4 | ||||||||
| IPC class: | A61K 38/39 A61K 38/16 C07K 16/18 G01N 33/50 G01N 33/574 A61P 35/00 |
||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | D | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | Use of heparin-binding domain of fibronectin for diagnosis and treatment of cancer | ||||||||
| Applicant name: | Novartis Forschungsstiftung, Zweigniederlassung | ||||||||
| Opponent name: | - | ||||||||
| Board: | 3.3.04 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: |
|
||||||||
| Keywords: | Reimbursement of appeal fee - (no) Claims - clarity Claims - main request (no) Claims - clarity Claims - auxiliary request (no) |
||||||||
| Catchwords: |
- |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t102106eu1.html
Date retrieved: 17 May 2021